Acellular Pertussis Completed Phase 4 Trials for Chlorpheniramine (DB01114)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs